As the Latest Data Show, Monoclonal Antibodies Sotrovimab and Casirivimab-imdevimab Do Not ... - Latest Tweet by World Health Organization
The latest Tweet by World Health Organization states, 'As the latest data show, monoclonal antibodies sotrovimab and casirivimab-imdevimab do not seem to be effective against circulating variants, including Omicron. They should not be used to treat #COVID19....'
As the latest data show, monoclonal antibodies sotrovimab and casirivimab-imdevimab do not seem to be effective against circulating variants, including Omicron. They should not be used to treat #COVID19.https://t.co/TWKxRYhePK— World Health Organization (WHO) (@WHO) September 20, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Sep 20, 2022 03:24 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
